Hyundai Pharmaceutical Co (XKRX:004310) EV-to-EBITDA : 12.22 (As of May. 27, 2024)

Hyundai Pharmaceutical Co EV-to-EBITDA Chart

Hyundai Pharmaceutical Co Annual Data
	Trend	Nov14	Nov15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22	Nov23
EV-to-EBITDA		Get a 7-Day Free Trial					26.70	24.95	216.22	13.66	9.51

Hyundai Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-EBITDA	Get a 7-Day Free Trial															14.06	13.17	13.09	9.51	12.43

Competitive Comparison of Hyundai Pharmaceutical Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Hyundai Pharmaceutical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hyundai Pharmaceutical Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hyundai Pharmaceutical Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Hyundai Pharmaceutical Co's EV-to-EBITDA falls into.

Hyundai Pharmaceutical Co EV-to-EBITDA Calculation

Hyundai Pharmaceutical Co's EV-to-EBITDA for today is calculated as:

Hyundai Pharmaceutical Co's current Enterprise Value is ₩124,813 Mil.
Hyundai Pharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩10,210 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hyundai Pharmaceutical Co  (XKRX:004310) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Hyundai Pharmaceutical Co's PE Ratio for today is calculated as:

Hyundai Pharmaceutical Co's share price for today is ₩3735.00.
Hyundai Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩177.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Hyundai Pharmaceutical Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Hyundai Pharmaceutical Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyundai Pharmaceutical Co (XKRX:004310) Business Description